Hubei Jumpcan Pharmaceutical Balance Sheet Health
Financial Health criteria checks 5/6
Hubei Jumpcan Pharmaceutical has a total shareholder equity of CN¥14.2B and total debt of CN¥1.7B, which brings its debt-to-equity ratio to 11.9%. Its total assets and total liabilities are CN¥19.4B and CN¥5.1B respectively. Hubei Jumpcan Pharmaceutical's EBIT is CN¥3.0B making its interest coverage ratio -7.8. It has cash and short-term investments of CN¥12.8B.
Key information
11.9%
Debt to equity ratio
CN¥1.69b
Debt
| Interest coverage ratio | -7.8x |
| Cash | CN¥12.83b |
| Equity | CN¥14.22b |
| Total liabilities | CN¥5.15b |
| Total assets | CN¥19.36b |
Recent financial health updates
Recent updates
Is Hubei Jumpcan Pharmaceutical (SHSE:600566) A Risky Investment?
Aug 07
Is Now The Time To Put Hubei Jumpcan Pharmaceutical (SHSE:600566) On Your Watchlist?
Jul 01Hubei Jumpcan Pharmaceutical Co., Ltd.'s (SHSE:600566) Prospects Need A Boost To Lift Shares
May 30Hubei Jumpcan Pharmaceutical (SHSE:600566) Ticks All The Boxes When It Comes To Earnings Growth
Mar 17Financial Position Analysis
Short Term Liabilities: 600566's short term assets (CN¥15.5B) exceed its short term liabilities (CN¥5.0B).
Long Term Liabilities: 600566's short term assets (CN¥15.5B) exceed its long term liabilities (CN¥184.2M).
Debt to Equity History and Analysis
Debt Level: 600566 has more cash than its total debt.
Reducing Debt: 600566's debt to equity ratio has increased from 9.3% to 11.9% over the past 5 years.
Debt Coverage: 600566's debt is well covered by operating cash flow (206.8%).
Interest Coverage: 600566 earns more interest than it pays, so coverage of interest payments is not a concern.